Alicea et al. reported that inhibiting FA transport protein 2 diminishes lipid uptake and mitochondrial function, effectively restoring melanoma cell sensitivity to BRAF/MEK inhibitors[91]. The gene discussed is BRAF; the disease is melanoma.